CPS Technologies (CPSH) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
29 Jan, 2026Executive summary
Achieved record Q3 2025 revenue of $8.8 million, more than doubling year-over-year, marking the third consecutive quarter of record sales and driven by strong demand in MMC, hermetic packages, and higher SBIR funding.
Gross margin improved to 17.1% from a gross loss in the prior-year period, reflecting higher sales, production efficiencies, and better absorption of fixed costs.
Net income for Q3 2025 was just over $200,000 ($0.01 per share), compared to a net loss of $1 million ($0.07 per share) last year.
Secured a $15.5 million power module contract with a multinational semiconductor manufacturer, reflecting a 16.5% year-over-year increase in value.
Completed a secondary public offering, raising $9.5 million in net proceeds to fund a move to a larger manufacturing facility and support expansion.
Financial highlights
Revenue for Q3 2025 was $8.8 million, up from $4.2 million in Q3 2024.
Gross profit was $1.5 million (17.1% margin), compared to a gross loss of $500,000 (-12.3% margin) last year.
Operating profit was $276,000, reversing a $1.5 million operating loss in Q3 2024.
Net income margin was 2.4% for the quarter.
SG&A expenses were $1.2 million, up from $963,000 in the prior year due to higher compensation, commissions, and FX impacts.
Outlook and guidance
Management expects 2025 to be the best sales year ever, with continued focus on margin expansion and operational improvements.
Fiscal 2026 is anticipated to remain strong, with continued growth in demand and new contracts.
The new manufacturing facility, expected to be operational in 2026, will nearly double floor space and support long-term growth.
Margins are expected to improve further as new contracts ramp and operational efficiencies increase.
Proceeds from the $9.5 million equity raise will fund facility expansion and capital expenditures.
Latest events from CPS Technologies
- 2026 meeting seeks approval for directors, executive pay, share increase, and auditor ratification.CPSH
Proxy filing20 Mar 2026 - Annual meeting to vote on directors, executive pay, share increase, and auditor ratification.CPSH
Proxy Filing10 Mar 2026 - Record revenue, margin gains, and facility expansion drive strong growth outlook.CPSH
Q4 20253 Mar 2026 - Revenue and margins fell in Q2, but new contracts and product launches support future growth.CPSH
Q2 20242 Feb 2026 - Record Q2 2025 revenue, profitability, and strong demand drive a positive outlook.CPSH
Q2 202529 Jan 2026 - Record Q1 2025 revenue and profitability, with strong growth and improved margins.CPSH
Q1 202529 Jan 2026 - Q3 revenue fell 32% to $4.2M, but new contracts and capacity boost outlook for 2025.CPSH
Q3 202429 Jan 2026 - Record revenue, $12M order, and new contracts drive growth and innovation outlook.CPSH
21st Virtual Investor Summit Microcap Event12 Jan 2026 - Sequential revenue growth and new contracts position the company for a stronger 2025.CPSH
Q4 202426 Dec 2025